News | Cardiac Imaging | July 11, 2023

Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke initiatives

In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke initiatives

(Photo: Business Wire)


July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR). To support its acute stroke care initiatives, Hyperfine Inc. has formed an advisory board of world-renowned stroke experts.

As a prospective, international, multi-site observational study, ACTION PMR aims to examine the integration of brain imaging with the Swoop system into the stroke diagnosis and treatment workflow. The goal is to use point-of-care brain imaging to identify strokes and viable brain tissue that can be saved.

MRI scans, which are more precise than CT scans, are recommended for diagnosing acute ischemic stroke within twelve hours of symptom onset by the American Academy of Neuroradiology. However, the limited availability of MRI scanners near acute care settings in many hospitals highlights the need for point-of-care MR brain imaging.

“The ACTION PMR study has the potential to improve stroke treatment all over the world, with the Swoop system assisting clinicians in imaging brain tissue and making timely diagnoses which could lead to the implementation of more effective treatments and help to facilitate better patient outcomes,” says Dr. Khan Siddiqui, Hyperfine, Inc. Chief Medical Officer and Chief Strategy Officer.

Four investigators from leading institutions will lead the study: Dr. W. Taylor Kimberly of Massachusetts General Hospital, Dr. Adnan Siddiqui of the University at Buffalo, Dr. Vivien Lee of the Ohio State University Wexner Medical Center, and Dr. Keith Muir of the University of Glasgow.

“Refining stroke diagnosis and care is central to all we do; as such, our research will focus on patients who don’t immediately qualify for thrombectomy,” says Dr. Taylor Kimberly of Massachusetts General Hospital. “We hope this study may contribute to timelier diagnoses, paving the way for improved patient outcomes.”

Alongside the ACTION PMR study, the newly formed stroke advisory board, comprised of experts in the field, will provide insights and experiences to guide and define the impact the Swoop system can have in the fast-evolving field of acute stroke care.

Maria Sainz, Hyperfine, Inc. President and CEO, adds, "There is a significant unmet need in stroke imaging and workflow representing a very compelling incremental opportunity for Hyperfine, Inc. Our ambition is to enable innovative and readily accessible brain imaging solutions that enhance the chances of recovery for every patient. ACTION PMR is an important project for us, and we are honored to be working with our distinguished clinical investigators and stroke advisors to navigate the challenges and opportunities in stroke care and formulate the role the Swoop® system can play in acute stroke workflow.”

For more information: https://hyperfine.io/


Related Content

News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Home September 21, 2023
Home
Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

Home July 10, 2023
Home
News | Cardiac Imaging

June 29, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home June 29, 2023
Home
News | Cardiac Imaging

June 26, 2023 — Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...

Home June 26, 2023
Home
News | Cardiac Imaging

June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and ...

Home June 15, 2023
Home
News | Cardiac Imaging

June 9, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home June 09, 2023
Home
Feature | Cardiac Imaging | By Mohammad Sahebjalal, MD

Invented in 1896 by Enrico Salvioni, the fluoroscope remains a flagship technology of modern medicine. The live video X ...

Home May 04, 2023
Home
News | Cardiac Imaging

April 26, 2023 — In the majority of cases, graft failure after heart transplantation is attributable to abnormalities ...

Home April 26, 2023
Home
News | Cardiac Imaging

April 14, 2023 — Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced that the U.S ...

Home April 14, 2023
Home
News | Cardiac Imaging

February 8, 2023 — Carestream Health is partnering with Robarts Research Institute to increase and demonstrate the ...

Home February 08, 2023
Home
Subscribe Now